These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 1423930

  • 1. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N, Stuart JS, Lamp ST, Alexander LD, Weiss JN.
    Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
    Shigematsu S, Sato T, Abe T, Saikawa T, Sakata T, Arita M.
    Circulation; 1995 Oct 15; 92(8):2266-75. PubMed ID: 7554211
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ, D'Alonzo AJ, Garlid KD, Bajgar R, Lodge NJ, Sleph PG, Darbenzio RB, Hess TA, Smith MA, Paucek P, Atwal KS.
    J Pharmacol Exp Ther; 2001 Jun 15; 297(3):1184-92. PubMed ID: 11356945
    [Abstract] [Full Text] [Related]

  • 4. K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias.
    Remme CA, Schumacher CA, de Jong JW, Fiolet JW, de Groot JR, Coronel R, Wilde AA.
    J Cardiovasc Pharmacol; 2001 Sep 15; 38(3):406-16. PubMed ID: 11486245
    [Abstract] [Full Text] [Related]

  • 5. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB.
    Cardiovasc Res; 1995 Nov 15; 30(5):731-8. PubMed ID: 8595620
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.
    Grover GJ, D'Alonzo AJ, Parham CS, Darbenzio RB.
    J Cardiovasc Pharmacol; 1995 Jul 15; 26(1):145-52. PubMed ID: 7564356
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-1 partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells.
    Kobayashi S, Nakaya H, Takizawa T, Hara Y, Kimura S, Saito T, Masuda Y.
    J Cardiovasc Pharmacol; 1996 Jan 15; 27(1):12-9. PubMed ID: 8656645
    [Abstract] [Full Text] [Related]

  • 8. Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle.
    Venkatesh N, Lamp ST, Weiss JN.
    Circ Res; 1991 Sep 15; 69(3):623-37. PubMed ID: 1908355
    [Abstract] [Full Text] [Related]

  • 9. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A, Szerdahelyi P, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1355-62. PubMed ID: 8263798
    [Abstract] [Full Text] [Related]

  • 10. ATP-sensitive K+ channels and cellular K+ loss in hypoxic and ischaemic mammalian ventricle.
    Weiss JN, Venkatesh N, Lamp ST.
    J Physiol; 1992 Feb 15; 447():649-73. PubMed ID: 1593462
    [Abstract] [Full Text] [Related]

  • 11. alpha 1-Adrenoceptor stimulation partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells: attenuation of the action potential shortening induced by hypoxia and K+ channel openers.
    Takizawa T, Hara Y, Saito T, Masuda Y, Nakaya H.
    J Cardiovasc Pharmacol; 1996 Dec 15; 28(6):799-808. PubMed ID: 8961078
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA, Atwal KS.
    J Cardiovasc Pharmacol; 1995 Jan 15; 25(1):40-50. PubMed ID: 7723352
    [Abstract] [Full Text] [Related]

  • 13. BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle.
    Sanguinetti MC, Scott AL, Zingaro GJ, Siegl PK.
    Proc Natl Acad Sci U S A; 1988 Nov 15; 85(21):8360-4. PubMed ID: 2460868
    [Abstract] [Full Text] [Related]

  • 14. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
    Taki H, Masuda Y, Yoshizumi M, Kitagawa T, Katoh I.
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar 15; 41(3):438-44. PubMed ID: 8478573
    [Abstract] [Full Text] [Related]

  • 15. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A, Hellegouarch A.
    J Am Coll Cardiol; 1994 Feb 15; 23(2):487-96. PubMed ID: 8294705
    [Abstract] [Full Text] [Related]

  • 16. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
    McPherson CD, Pierce GN, Cole WC.
    Am J Physiol; 1993 Nov 15; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of cromakalim on ischemic and reperfused immature heart: experiments with isolated neonatal New Zealand white rabbit hearts.
    Shimoe Y, Yoshizumi M, Masuda Y, Kitagawa T, Katoh I.
    Tokushima J Exp Med; 1996 Dec 15; 43(3-4):135-41. PubMed ID: 9100462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC, Gunter HE, Kuzio B, Shoemaker L, Yang L, Deslauriers R.
    J Mol Cell Cardiol; 1997 Jun 15; 29(6):1665-73. PubMed ID: 9220352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.